Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.
about
Mesalamine in the treatment and maintenance of remission of ulcerative colitisLong-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine.Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiologyOral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.5-ASA colonic mucosal concentrations resulting from different pharmaceutical formulations in ulcerative colitis.Topical therapies in inflammatory bowel disease.Topical therapy.Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis.Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations.Development of the rectal dosage form with silver-coated glass beads for local-action applications in lower sections of the gastrointestinal tract.Dissolution of mesalazine modified release tablets under standard and bio-relevant test conditions.5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.Inaccuracies concerning Salofalk granules
P2860
Q26865546-78C21D66-C907-4041-894A-52BC0321D0E9Q34273329-E2521CCE-76B7-477D-B19F-8C6A390CA4B1Q36144377-F1FC84A0-567C-4202-AE5F-C489FD9E51B2Q36245600-9B1538CA-E5F9-489B-A352-CF7AED01A624Q36997021-F31B3527-4340-45AE-A6DE-CAB5DCE1F2CEQ37162453-6E8FD723-CBA9-42C3-A217-CD5D0E46BC2EQ38050885-F9F67A42-0B15-4A6D-8C6D-C6F066D440FBQ38072231-09915DF6-44C6-44B3-8DDA-41E4C990C3E1Q38144113-7FE84C45-DCB5-41A2-BA29-8EF3D3352AFAQ38505808-CC26EF3D-C956-4F13-9201-D0F5FB7F93FAQ39401950-C2FE12FC-7149-4D4B-A504-ECE33F29901BQ47865901-3174C41D-B802-44D1-A392-CF5312139A61Q53347908-31E3D031-3ACC-454A-8E8E-FF2E959A8FF8Q53496153-FF9B1490-5808-4DA4-A75F-AE35D30C42CEQ54224453-E3C3E83E-7A67-4E36-97B4-D0BD7306682DQ57379098-F86BA57B-27B0-417C-AD55-32E972FFA444
P2860
Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review article: delivery and e ...... eatment of ulcerative colitis.
@en
Review article: delivery and efficacy of topical 5-aminosalicylic acid
@nl
type
label
Review article: delivery and e ...... eatment of ulcerative colitis.
@en
Review article: delivery and efficacy of topical 5-aminosalicylic acid
@nl
prefLabel
Review article: delivery and e ...... eatment of ulcerative colitis.
@en
Review article: delivery and efficacy of topical 5-aminosalicylic acid
@nl
P2860
P1476
Review article: delivery and e ...... eatment of ulcerative colitis.
@en
P2093
G R Lichtenstein
M S Harris
P2860
P304
P356
10.1111/J.1365-2036.2011.04619.X
P407
P577
2011-03-08T00:00:00Z